|
Product Name
|
Listing Number
|
Price
|
|
EndoPAT
|
292238
|
$29,500.00
|
|
|
Description
|
|
EndoPAT is the leading medical device for noninvasive endothelial function assessment. It is FDA-cleared and is becoming widely recognized as the standard method for endothelial function assessment. Some of the features that make EndoPAT appealing are its ease of use, user-independence
and immediate, automatically calculated test results. It provides clinicians with a reliable and reproducible index of endothelial function in a 15-minute, office-based test. Some benefits of the EndoPAT include:
*CPT coded (93923) for simple billing and minimal conflict with insurance companies
*Increases office revenue while simultaneously increasing the patients’ quality of care and quality of life
*Provides incremental data to better predict and treat patients at risk for CVD, patients who would otherwise go undetected.
*Doctors can more effectively monitor treatment for better patient outcomes.
*Measures earliest signs of atherosclerosis, while it is still reversible
Endo-PAT testing is reimbursable by Medicare and covered by most major U.S. insurance companies.
For more information: www.medvica.com
|
|
|
Condition
|
Quantity Available
|
Date Available
|
|
|
Unlimited
|
Immediate
|
|
|
Manufacturer
|
Model Number
|
Model Year
|
|
Itamar
|
|
2000
|
|
|
Serial Number
|
Inventory Number
|
SKU Number
|
|
FG1600012
|
|
|
|
|
Shipping
|
Product Location
|
Location Zip Code
|
|
Ships within 2 days of purchase.
|
|
|
|
|
Return Policy
|
|
All sales are final.
|
|
|
Acceptable Payment Types
|
|
All payments may be made by check or credit card. We currently accept Visa and MasterCard. Please make checks payable to: Clinical Research Services, Inc. Credit Card information can be faxed to (520) 219 -5283
|
|
|
Terms and Conditions
|
|
Available upon request.
|
|
|